Pharmacogenomics of coumarin anticoagulants: Are we underestimating the role of CYP2C9?

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH08-07-0425
Issue:2008: 100/2 (Aug) pp. 173-364
Pages:175-176

Pharmacogenomics of coumarin anticoagulants: Are we underestimating the role of CYP2C9?

Tom Schalekamp, Anke-Hilse Maitland – van der Zee, Anthonius de Boer
Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Utrecht, The Netherlands

DOI

http://dx.doi.org/10.1160/TH08-07-0425

Articles

You've 499 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...